[CITATION][C] Mortality and morbidity among infants at high risk receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis
PA Checchia, L Nalysnyk, AW Fernandes…�- Pediatr Crit Care Med, 2011
Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review�…
PA Checchia, L Nalysnyk, AW Fernandes…�- Pediatric Critical Care�…, 2011 - journals.lww.com
Objectives: A systematic literature review and meta-analysis was performed to evaluate the
impact of prophylaxis with palivizumab on mortality and morbidity associated with respiratory
syncytial virus infection in infants at high risk (≤ 35 wks of gestational age, chronic lung
disease, or congenital heart disease). Data Sources: MEDLINE, EMBASE, and Current
Contents were used. MEDLINE was searched from January 1, 1990 to May 16, 2007. The
bibliographies of accepted studies and recent reviews and proceedings from the past 2 yrs�…
impact of prophylaxis with palivizumab on mortality and morbidity associated with respiratory
syncytial virus infection in infants at high risk (≤ 35 wks of gestational age, chronic lung
disease, or congenital heart disease). Data Sources: MEDLINE, EMBASE, and Current
Contents were used. MEDLINE was searched from January 1, 1990 to May 16, 2007. The
bibliographies of accepted studies and recent reviews and proceedings from the past 2 yrs�…
Showing the best results for this search. See all results